Shortened daily regimen for tuberculosis treatment which enables better drug compliance and gives the patients better chance at completing treatment is the aim of a study that the Indian Council of Medical Research-National Institute of Research in Tuberculosis (NIRT), Chennai, is all set to undertake.
NIRT’s multi-centric study — to be carried out in Nagpur, Lucknow, Vellor and Delhi — will evaluate the efficacy of a four-month daily regimen for TB treatment using Moxifloxacin, a drug used to prevent the disease as compared with the existing six-month course.
Under the National TB Elimination Program (NTEP), the anti-TB drugs are offered as fixed-dose combinations (FDC) and a pilot study for this has been completed.
